Senate bill S4152-117

Health, Education, Labor, and Pensions Committee

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

• Last activity on May 05, 2022

• Introduced May 05, 2022

• By Sen. Kelly, Mark [D-AZ]

Support this bill

Main Subject: Health

This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.

HR7667-117, HR7658-117, S4348-117,

Senate Actions

IntroReferral
May. 05 2022	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Library of Congress Actions

IntroReferral
May. 05 2022	Introduced in Senate

Senate bill S4152-117

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Promote the cause!

Or use this QR code